ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 118 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,938 | +700.8% | 75,845 | +652.0% | 0.02% | +633.3% |
Q1 2023 | $242 | -99.9% | 10,086 | -55.5% | 0.00% | -25.0% |
Q2 2022 | $357,000 | +61.5% | 22,678 | +280.2% | 0.00% | +300.0% |
Q4 2021 | $221,000 | -68.7% | 5,965 | -59.6% | 0.00% | -66.7% |
Q3 2021 | $706,000 | +132.2% | 14,767 | +100.8% | 0.00% | +50.0% |
Q1 2021 | $304,000 | -60.5% | 7,355 | -59.0% | 0.00% | -60.0% |
Q3 2020 | $769,000 | +122.9% | 17,931 | +143.0% | 0.01% | +66.7% |
Q2 2020 | $345,000 | – | 7,380 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DFPG INVESTMENTS, LLC | 456,390 | $5,541,000 | 3.62% |
DAFNA Capital Management LLC | 173,914 | $1,890,000 | 0.65% |
One68 Global Capital, LLC | 19,861 | $216,000 | 0.47% |
Diametric Capital, LP | 51,982 | $565,000 | 0.41% |
ARK Investment Management | 1,383,756 | $15,041,000 | 0.38% |
EAM Investors, LLC | 52,833 | $574,000 | 0.13% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 31,404 | $341,000 | 0.05% |
Nikko Asset Management Americas, Inc. | 280,548 | $3,050,000 | 0.05% |
MGO ONE SEVEN LLC | 14,900 | $161,000 | 0.04% |
Qube Research & Technologies Ltd | 67,702 | $736,000 | 0.02% |